Kent R. Buhler

1.3k total citations
22 papers, 1.0k citations indexed

About

Kent R. Buhler is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kent R. Buhler has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kent R. Buhler's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Biotin and Related Studies (5 papers). Kent R. Buhler is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Biotin and Related Studies (5 papers). Kent R. Buhler collaborates with scholars based in United States and France. Kent R. Buhler's co-authors include Robert L. Vessella, Eva Corey, Janna E. Quinn, Lawrence D. True, Donald K. Hamlin, Pradip M. Pathare, Peter de Vries, Jack W. Singer, Franck Bladou and D. Scott Wilbur and has published in prestigious journals such as Journal of Controlled Release, The Journal of Urology and American Journal Of Pathology.

In The Last Decade

Kent R. Buhler

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kent R. Buhler United States 16 503 401 288 155 129 22 1.0k
Ada Gjyrezi United States 9 338 0.7× 385 1.0× 236 0.8× 108 0.7× 181 1.4× 15 833
Patrick Delavault France 9 315 0.6× 294 0.7× 206 0.7× 144 0.9× 242 1.9× 15 1.3k
Sanjay Thamake United States 15 334 0.7× 161 0.4× 235 0.8× 112 0.7× 136 1.1× 28 791
Jer Tsong Hsieh United States 8 319 0.6× 209 0.5× 126 0.4× 35 0.2× 70 0.5× 11 597
Mary Brummet United States 22 355 0.7× 414 1.0× 369 1.3× 452 2.9× 35 0.3× 47 1.3k
Marianne Budde Netherlands 12 553 1.1× 181 0.5× 359 1.2× 716 4.6× 84 0.7× 14 1.4k
Chen Sun China 16 582 1.2× 629 1.6× 114 0.4× 52 0.3× 41 0.3× 34 1.1k
Anthony Cheung United Kingdom 12 354 0.7× 80 0.2× 361 1.3× 220 1.4× 114 0.9× 18 884
Mozhdeh Sojoodi United States 20 482 1.0× 82 0.2× 447 1.6× 109 0.7× 88 0.7× 38 1.4k
Marilynn Vetzel United States 17 540 1.1× 109 0.3× 483 1.7× 324 2.1× 222 1.7× 28 1.3k

Countries citing papers authored by Kent R. Buhler

Since Specialization
Citations

This map shows the geographic impact of Kent R. Buhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent R. Buhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent R. Buhler more than expected).

Fields of papers citing papers by Kent R. Buhler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent R. Buhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent R. Buhler. The network helps show where Kent R. Buhler may publish in the future.

Co-authorship network of co-authors of Kent R. Buhler

This figure shows the co-authorship network connecting the top 25 collaborators of Kent R. Buhler. A scholar is included among the top collaborators of Kent R. Buhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent R. Buhler. Kent R. Buhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaffer, Scott A., et al.. (2006). In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemotherapy and Pharmacology. 59(4). 537–548. 84 indexed citations
2.
Corey, Eva, Janna E. Quinn, Kent R. Buhler, et al.. (2003). LuCaP 35: A new model of prostate cancer progression to androgen independence. The Prostate. 55(4). 239–246. 120 indexed citations
3.
True, Lawrence D., Kent R. Buhler, Janna E. Quinn, et al.. (2002). A Neuroendocrine/Small Cell Prostate Carcinoma Xenograft—LuCaP 49. American Journal Of Pathology. 161(2). 705–715. 40 indexed citations
4.
Corey, Eva, Janna E. Quinn, Franck Bladou, et al.. (2002). Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells. The Prostate. 52(1). 20–33. 153 indexed citations
5.
Gerstein, Amy, Teresa Almeida, Guojing Zhao, et al.. (2002). APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers. Genes Chromosomes and Cancer. 34(1). 9–16. 118 indexed citations
6.
Singer, Jack W., Rama Bhatt, John Tulinsky, et al.. (2001). Water-soluble poly-(l-glutamic acid)–Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo. Journal of Controlled Release. 74(1-3). 243–247. 108 indexed citations
7.
Swanson, Kristin R., Lawrence D. True, Daniel W. Lin, et al.. (2001). A Quantitative Model for the Dynamics of Serum Prostate-Specific Antigen as a Marker for Cancerous Growth. American Journal Of Pathology. 158(6). 2195–2199. 45 indexed citations
8.
Buhler, Kent R., Richard A. Santucci, S Whitney, et al.. (2000). Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model. The Prostate. 43(1). 63–70. 16 indexed citations
9.
Wilbur, D. Scott, Pradip M. Pathare, Donald K. Hamlin, et al.. (1999). Development of new biotin/streptavidin reagents for pretargeting. Biomolecular Engineering. 16(1-4). 113–118. 36 indexed citations
10.
Buhler, Kent R., Janna E. Quinn, S Whitney, et al.. (1999). THE LuCaP SERIES OF HUMAN PROSTATE CANCER XENOGRAFTS. The Journal of Urology. 58–58. 3 indexed citations
11.
Buhler, Kent R., Eva Corey, James E. Stray, & Robert L. Vessella. (1998). Study of free and complexed prostate-specific antigen in mice bearing human prostate cancer xenografts. The Prostate. 36(3). 194–200. 5 indexed citations
12.
Corey, Eva, et al.. (1998). LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen. The Prostate. 35(2). 135–143. 20 indexed citations
13.
Wilbur, D. Scott, Patrick S. Stayton, Kent R. Buhler, et al.. (1998). Streptavidin in Antibody Pretargeting. Comparison of a Recombinant Streptavidin with Two Streptavidin Mutant Proteins and Two Commercially Available Streptavidin Proteins. Bioconjugate Chemistry. 9(1). 100–107. 22 indexed citations
14.
Corey, Eva, Lisha G. Brown, Michael J. Corey, Kent R. Buhler, & Robert L. Vessella. (1998). LNCaP produces both putative zymogen and inactive, free form of prostate‐specific antigen. The Prostate. 35(2). 135–143. 1 indexed citations
15.
Wilbur, D. Scott, Pradip M. Pathare, Donald K. Hamlin, Kent R. Buhler, & Robert L. Vessella. (1998). Biotin Reagents for Antibody Pretargeting. 3. Synthesis, Radioiodination, and Evaluation of Biotinylated Starburst Dendrimers. Bioconjugate Chemistry. 9(6). 813–825. 84 indexed citations
16.
Wilbur, D. Scott, Donald K. Hamlin, Kent R. Buhler, et al.. (1998). Streptavidin in Antibody Pretargeting. 2. Evaluation of Methods for Decreasing Localization of Streptavidin to Kidney while Retaining Its Tumor Binding Capacity. Bioconjugate Chemistry. 9(3). 322–330. 25 indexed citations
17.
Corey, Eva, Kent R. Buhler, & Robert L. Vessella. (1997). Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Urology. 50(4). 567–572. 11 indexed citations
18.
Bladou, Franck, Robert L. Vessella, Kent R. Buhler, et al.. (1996). Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration. International Journal of Cancer. 67(6). 785–790. 50 indexed citations
19.
Wilbur, D. Scott, Donald K. Hamlin, Robert L. Vessella, et al.. (1996). Antibody Fragments in Tumor Pretargeting. Evaluation of Biotinylated Fab‘ Colocalization with Recombinant Streptavidin and Avidin. Bioconjugate Chemistry. 7(6). 689–702. 36 indexed citations
20.
Wilbur, D. Scott, Donald K. Hamlin, Pradip M. Pathare, et al.. (1996). Synthesis and nca-Radioiodination of Arylstannyl−Cobalamin Conjugates. Evaluation of Aryliodo−Cobalamin Conjugate Binding to Transcobalamin II and Biodistribution in Mice. Bioconjugate Chemistry. 7(4). 461–474. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ada Gjyrezi Breakdown of academic impact, for papers by Patrick Delavault Breakdown of academic impact, for papers by Sanjay Thamake Breakdown of academic impact, for papers by Jer Tsong Hsieh Breakdown of academic impact, for papers by Mary Brummet Breakdown of academic impact, for papers by Marianne Budde Breakdown of academic impact, for papers by Chen Sun Breakdown of academic impact, for papers by Anthony Cheung Breakdown of academic impact, for papers by Mozhdeh Sojoodi Breakdown of academic impact, for papers by Marilynn Vetzel
Rankless by CCL
2026